发明名称 |
IBRUTINIB COMBINATION THERAPY |
摘要 |
Combinations of Bruton's tyrosine kinase (Btk) inhibitors, e.g., 1-((R)-3-(4-amino-phenoxyphenyl)- 1 H-pyrazolo [3,4-d]pyrimidin- 1 -yl)piperidin- 1 -yl)prop-2-en- 1 -one, with a second anticancer agent are provided. Also provided are methods of treating cancers, and autoimmune disorders by administering combinations of Bruton's tyrosine kinase (Btk) inhibitors, e.g., 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl)piperidin-1-yl)prop-2-en-1-one, and second anticancer agents. |
申请公布号 |
CA2908375(A1) |
申请公布日期 |
2014.10.16 |
申请号 |
CA20142908375 |
申请日期 |
2014.04.08 |
申请人 |
PHARMACYCLICS LLC;JANSSEN PHARMACEUTICA NV |
发明人 |
CHANG, BETTY;BALASUBRAMANIAN, SRIRAM;CROWLEY, RICHARD;KUO, HSU-PING;HALL, BRETT;SASSER, A. KATE;SCHAFFER, MICHAEL;DAVIS, CUC;CASNEUF, TINEKE;VERSELE, MATTHIAS;LIGTENBERG, WILLEM |
分类号 |
A61K31/519;A61K31/56;A61K31/573;A61P35/00 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|